Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PT Prodia Utama is the holding company for the Prodia Group, the largest clinical laboratory network in Indonesia. Through its primary subsidiary, PT Prodia Widyahusada Tbk, the company provides comprehensive diagnostic services, including genomic testing and routine clinical pathology. The group also encompasses specialized units such as PT Prodia Stem Cell Indonesia (ProSTEM), which focuses on regenerative medicine and stem cell storage, and PT Prodia Diagnostic Line (Proline), which manufactures in vitro diagnostic reagents. With a history spanning over five decades, PT Prodia Utama plays a central role in the Indonesian healthcare ecosystem by integrating laboratory services, digital health solutions, and biotechnology research. The company is recognized for its commitment to quality, being the first in Indonesia to receive accreditation from the College of American Pathologists (CAP).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PT Prodia Utama.